在CAR-T细胞治疗后的抗原损失:机制,影响和潜在的解决方案
Archana Mishra1, Rituparna Maiti1, Prafull Mohan2
1Department of Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
European journal of haematology
|September 14, 2023
概括
化学抗原受体T细胞 (CAR-T) 疗法显示出希望,但面临挑战. 癌细胞中的抗原损失可能导致疾病复发,限制CAR-T细胞的有效性,并需要新的策略.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体T细胞 (CAR-T) 治疗是一种革命性的血液恶性瘤治疗方法.
- 卡-T细胞是工程免疫细胞,它们向并摧毁表达特定抗原的癌细胞.
研究的目的:
- 审查CAR-T细胞治疗后抗原损失的机制.
- 讨论抗原损失对治疗结果的临床影响.
- 探索在CAR-T疗法中克服抗原损失的策略.
主要方法:
- 在PubMed/MEDLINE,EMBASE和谷歌学者的系统文献搜索.
- 对研究抗原损失或下调后CAR-T治疗的研究分析.
- 综合了有关机制,结果和对策的发现.
主要成果:
- 在CAR-T治疗后复发性疾病的患者中,抗原损失或下调发生在30%-70%的患者中.
- 这种现象使CAR-T细胞无效,导致疾病复发.
- 抗原损失的机制各不相同,导致治疗失败.
结论:
- 抗原损失是影响血液恶性瘤中CAR-T疗法疗效的关键挑战.
- 了解抗原损失机制对于开发改进的治疗策略至关重要.
- 需要进一步的研究来克服抗原逃逸并提高患者的长期治疗结果.
相关概念视频
Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Cell-mediated Immune Responses
68.8K
Overview
68.8K
T Cell Activation and Clonal Selection
801
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
801
Cytotoxic T Cells-mediated Immune Response
959
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
959


